Journal article
The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial
Abstract
AIMS: No antithrombotic therapy has been shown to reduce mortality when used with thrombolytics in acute myocardial infarction (AMI). In the OASIS-6 trial, fondaparinux significantly reduced mortality and reinfarction without increasing bleeding in 12 092 patients with acute ST elevation MI.
METHODS AND RESULTS: We report the results of a subgroup analysis in the 5436 patients (45%) receiving thrombolytics. According to local practice, 4415 …
Authors
Peters RJG; Joyner C; Bassand J-P; Afzal R; Chrolavicius S; Mehta SR; Oldgren J; Wallentin L; Budaj A; Fox KA
Journal
European Heart Journal, Vol. 29, No. 3, pp. 324–331
Publisher
Oxford University Press (OUP)
Publication Date
February 2008
DOI
10.1093/eurheartj/ehm616
ISSN
0195-668X